Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Assets (2016 - 2025)

Iradimed (IRMD) has disclosed Current Assets for 13 consecutive years, with $81.2 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 7.92% to $81.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $81.2 million through Dec 2025, up 7.92% year-over-year, with the annual reading at $81.2 million for FY2025, 7.92% up from the prior year.
  • Current Assets for Q4 2025 was $81.2 million at Iradimed, down from $84.9 million in the prior quarter.
  • The five-year high for Current Assets was $84.9 million in Q3 2025, with the low at $61.3 million in Q1 2023.
  • Average Current Assets over 5 years is $72.7 million, with a median of $72.8 million recorded in 2023.
  • The sharpest move saw Current Assets increased 19.63% in 2021, then fell 6.44% in 2023.
  • Over 5 years, Current Assets stood at $76.2 million in 2021, then rose by 1.63% to $77.5 million in 2022, then dropped by 1.92% to $76.0 million in 2023, then decreased by 1.0% to $75.2 million in 2024, then rose by 7.92% to $81.2 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $81.2 million, $84.9 million, and $77.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.